AVR
Anteris Technologies Global Corp.
$9.15
-1.72%
$890.7M
No data for this timeframe.
Vol
Market Cap$890.7M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders48 funds
Inst. Value$104.1M
Inst. Activity18 buys / 1 sells
Insider Activity3B / 0S
Insider Net $$35.4M
SEC Reports5
Exchange Nasdaq·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. DE·CIK 0002011514·Prev Close $9.31
Recent Activity
Jun 10, 2026
SEC
Director Susan Elizabeth Knight purchased $102K of AVR stock on the open market at $9.29/share, a conviction buy represe
INSIDER-BUY — Impact 4/10
Jun 8, 2026
other
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
Jun 7, 2026
Insider
Roberts David B acquired via exercise 17,580 shares
Director
Jun 7, 2026
Insider
Moss Gregory S. acquired via exercise 17,580 shares
Director
Jun 5, 2026
Insider
McDonnell Matthew surrendered for taxes 39,595 shares
Chief Financial Officer @ $9.83 ($389.2K)
May 22, 2026
SEC
Anteris Technologies Global Corp. filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $250
424B5 — Impact 6/10
May 12, 2026
SEC
Anteris Technologies reported Q1 2026 EPS of -$0.74, a 174% miss vs consensus of -$0.27, with revenue of $1.1M in line.
PRESS-RELEASE — Impact 7/10
Inst.
BlackRock, Inc. — DOUBLED
4,889,153 shares ($27.1M)
Price Targets
$15.33
+67.6% upside
Strong Buy
Current $9.15
Low $15.00
Median $15.00
High $16.00
3 analysts
$15.00
$16.00
Analyst Ratings
1Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 15, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| Mar 27, 2026 | Cantor Fitzgerald | REITERATE | Overweight → Overweight |
| Mar 11, 2026 | Wells Fargo | INITIATE | Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.22 ▼ -19.7% | $-0.27 — $-0.16 | 62% YoY | 4 |
| Next Q | $-0.25 ▼ -8.2% | $-0.28 — $-0.21 | 59% YoY | 4 |
| Current FY | $-1.08 ▼ -23.8% | $-1.18 — $-0.95 | 58% YoY | 3 |
| Next FY | $-0.98 ▼ -1.0% | $-1.03 — $-0.92 | 9% YoY | 3 |
Latest Reports
BULLISH
INSIDER-BUY
4/10
Director Susan Elizabeth Knight purchased $102K of AVR stock on the open market at $9.29/share, a conviction buy represe
Jun 10, 2026
BEARISH
424B5
6/10
Anteris Technologies Global Corp. filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $250
May 22, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $27.1M | DOUBLED |
| RA CAPITAL MANAGEMENT, L.P. | $16.6M | NEW |
| FMR LLC | $16.1M | DOUBLED |
| STATE STREET CORP | $6.8M | DOUBLED |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.8M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 7, 2026 | Roberts David | M | $0.00 |
| Jun 7, 2026 | Moss Gregory | M | $0.00 |
| Jun 5, 2026 | McDonnell Matthew | F | $389.2K |
| Jun 5, 2026 | McDonnell Matthew | M | $9.7K |
| Jun 2, 2026 | Knight Susan | BUY | $102.2K |
48 institutional holders with $104.1M total value (18,810,481 shares) as of 2026-Q1. Top holders: BlackRock,, RA, FMR. Net buying activity: 18 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 4,889,153 | $27.1M | 26.1% | DOUBLED +141.2% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 3,000,000 | $16.6M | 16.0% | NEW |
| 3 | FMR LLC | 2,901,350 | $16.1M | 15.5% | DOUBLED +7220.9% |
| 4 | STATE STREET CORP | 1,223,107 | $6.8M | 6.5% | DOUBLED +241.8% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 857,803 | $4.8M | 4.6% | — |
| 6 | Alyeska Investment Group, L.P. | 750,000 | $4.2M | 4.0% | — |
| 7 | AMERIPRISE FINANCIAL INC | 653,330 | $3.6M | 3.5% | — |
| 8 | VANGUARD FIDUCIARY TRUST CO | 476,344 | $2.6M | 2.5% | — |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 469,583 | $2.6M | 2.5% | — |
| 10 | LMR Partners LLP | 450,000 | $2.5M | 2.4% | — |
| 11 | GOLDMAN SACHS GROUP INC | 415,493 | $2.3M | 2.2% | — |
| 12 | Woodline Partners LP | 400,000 | $2.2M | 2.1% | — |
| 13 | Nuveen, LLC | 307,864 | $1.7M | 1.6% | DOUBLED +621.3% |
| 14 | Jain Global LLC | 303,286 | $1.7M | 1.6% | — |
| 15 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 227,910 | $1.3M | 1.2% | DOUBLED +125.9% |
| 16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 191,600 | $1.1M | 1.0% | — |
| 17 | MORGAN STANLEY | 165,358 | $917.7K | 0.9% | DOUBLED +105.7% |
| 18 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 123,580 | $685.9K | 0.7% | — |
| 19 | BARCLAYS PLC | 109,922 | $610.1K | 0.6% | — |
| 20 | Empower Advisory Group, LLC | 101,082 | $561.0K | 0.5% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | DOUBLED | 2,026,967 | 4,889,153 | +141.2% | $27.1M | 2026-Q1 |
| RA CAPITAL MANAGEMENT, L.P. | NEW | — | 3,000,000 | — | $16.6M | 2026-Q1 |
| FMR LLC | DOUBLED | 39,631 | 2,901,350 | +7220.9% | $16.1M | 2026-Q1 |
| STATE STREET CORP | DOUBLED | 357,809 | 1,223,107 | +241.8% | $6.8M | 2026-Q1 |
| Nuveen, LLC | DOUBLED | 42,681 | 307,864 | +621.3% | $1.7M | 2026-Q1 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | DOUBLED | 100,911 | 227,910 | +125.9% | $1.3M | 2026-Q1 |
| MORGAN STANLEY | DOUBLED | 80,378 | 165,358 | +105.7% | $917.7K | 2026-Q1 |
| MACQUARIE GROUP LTD | DOUBLED | 33,668 | 81,246 | +141.3% | $450.9K | 2026-Q1 |
| DEUTSCHE BANK AG\ | DOUBLED | 28,865 | 71,922 | +149.2% | $399.2K | 2026-Q1 |
| RHUMBLINE ADVISERS | ADD | 37,642 | 59,183 | +57.2% | $328.5K | 2026-Q1 |
| MetLife Investment Management, LLC | DOUBLED | 6,634 | 44,536 | +571.3% | $247.2K | 2026-Q1 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | DOUBLED | 15,796 | 37,191 | +135.4% | $206.4K | 2026-Q1 |
| Russell Investments Group, Ltd. | ADD | 6,536 | 9,760 | +49.3% | $54.2K | 2026-Q1 |
| Legal & General Group Plc | DOUBLED | 3,446 | 6,943 | +101.5% | $38.5K | 2026-Q1 |
| NISA INVESTMENT ADVISORS, LLC | DOUBLED | 288 | 4,799 | +1566.3% | $26.6K | 2026-Q1 |
| CWM, LLC | DOUBLED | 854 | 3,175 | +271.8% | $17.6K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 2 | 134 | +6600.0% | $744.00 | 2026-Q1 |
| PRICE T ROWE ASSOCIATES INC /MD/ | DOUBLED | 22,875 | 56,235 | +145.8% | $313.00 | 2026-Q1 |
| PNC FINANCIAL SERVICES GROUP, INC. | TRIM | 29 | 15 | -48.3% | $83.00 | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 10,631 | 61,067 | +474.4% | $304.7K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 20,866 | 37,157 | +78.1% | $185.4K | 2025-Q4 |
| MACQUARIE GROUP LTD | DOUBLED | 270 | 33,668 | +12369.6% | $168.0K | 2025-Q4 |
| MetLife Investment Management, LLC | TRIM | 21,644 | 6,634 | -69.3% | $33.1K | 2025-Q4 |
| PNC FINANCIAL SERVICES GROUP, INC. | DOUBLED | 5 | 29 | +480.0% | $145.00 | 2025-Q4 |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 12,802 | 22,875 | +78.7% | $115.00 | 2025-Q4 |
5 unique insiders with 8 transactions. Net insider value: $35.4M ($35.4M bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 7, 2026 | Roberts David B | Director | EXERCISE | 17,580 | — | — |
| Jun 7, 2026 | Moss Gregory S. | Director | EXERCISE | 17,580 | — | — |
| Jun 5, 2026 | McDonnell Matthew | Chief Financial Officer | TAX W/H | 39,595 | $9.83 | $389.2K |
| Jun 5, 2026 | McDonnell Matthew | Chief Financial Officer | EXERCISE | 2,001 | $4.84 | $9.7K |
| Jun 2, 2026 | Knight Susan Elizabeth | Director | BUY | 11,000 | $9.29 | $102.2K |
| Mar 4, 2026 | McDonnell Matthew | Chief Financial Officer | AWARD | 78,740 | — | — |
| Jan 22, 2026 | L1 Capital Pty Ltd | 10%+ Owner | BUY | 5,000,000 | $5.75 | $28.8M |
| Oct 28, 2025 | L1 Capital Pty Ltd | 10%+ Owner | BUY | 1,333,334 | $4.94 | $6.6M |
5 SEC filing reports analyzed. Sentiment: 1 bullish, 3 bearish, 0 mixed, 1 neutral. Avg impact: 5.6/10.
BULLISH
INSIDER-BUY
4/10
Director Susan Elizabeth Knight purchased $102K of AVR stock on the open market at $9.29/share, a co
Jun 10, 2026
BEARISH
424B5
6/10
Anteris Technologies Global Corp. filed a 424B5 prospectus supplement for an at-the-market (ATM) off
May 22, 2026
BEARISH
PRESS-RELEASE
7/10
Anteris Technologies reported Q1 2026 EPS of -$0.74, a 174% miss vs consensus of -$0.27, with revenu
May 12, 2026
NEUTRAL
EFFECT
4/10
Anteris Technologies Global Corp. has announced the effectiveness of its shelf registration statemen
Mar 16, 2026
BEARISH
8-K
7/10
Anteris Technologies Global Corp. reported its 2025 annual financial results, showing a significant
Feb 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (88% buy). Based on 8 analysts: 1 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$15.33 mean target
+67.6% upside
Strong Buy (3.00)
$15.00 Low
$16.00 High
| Metric | Value |
|---|---|
| Current Price | $9.15 |
| Target Low | $15.00 |
| Target Mean | $15.33 |
| Target Median | $15.00 |
| Target High | $16.00 |
| # Analysts | 3 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.22 | $-0.27 | $-0.16 | 61.8% | -19.7% | 1↑ 1↓ | $0.0B | 119.0% | 4 |
| Next Q 2026-09-30 |
$-0.25 | $-0.28 | $-0.21 | 59.0% | -8.2% | 1↑ 1↓ | $0.0B | 526.5% | 4 |
| Current FY 2026-12-31 |
$-1.08 | $-1.18 | $-0.95 | 57.6% | -23.8% | 1↑ 2↓ | $0.0B | 407.3% | 3 |
| Next FY 2027-12-31 |
$-0.98 | $-1.03 | $-0.92 | 9.3% | -1.0% | 2↑ 1↓ | $0.0B | 43.9% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.222 | |
| 7d ago | $-0.222 | |
| 30d ago | $-0.185 | -0.037 |
| 60d ago | $-0.185 | -0.037 |
| 90d ago | $-0.220 | -0.002 |
3 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 15, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Mar 27, 2026 | Cantor Fitzgerald | REITERATE | Overweight | Overweight |
| Mar 11, 2026 | Wells Fargo | INITIATE | — | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 6 | 1 | 0 | 0 | 88% | |
| May 1, 2026 | 1 | 7 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 1 | 7 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 1 | 6 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 1 | 6 | 1 | 0 | 0 | 88% | |
| Jan 1, 2026 | 1 | 6 | 1 | 0 | 0 | 88% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 8, 2026
other
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance
May 26, 2026
short_volume
Short Volume: AVR — 55.8% short (0.3M / 0.6M)
Short: 343,181 | Exempt: 1,540 | TRF Vol: 614,954 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: AVR — 59.5% short (0.4M / 0.6M)
Short: 380,994 | Exempt: 0 | TRF Vol: 640,523 | Short Ratio: 59.5% | Off-exchange volume (dark pool + OTC)
May 14, 2026
short_volume
Short Volume: AVR — 60.7% short (0.3M / 0.5M)
Short: 332,621 | Exempt: 0 | TRF Vol: 547,582 | Short Ratio: 60.7% | Off-exchange volume (dark pool + OTC)
May 13, 2026
other
Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors
Appointment of Ms. Susan Knight and Mr. Stephen Denaro to the Board of Directors
May 12, 2026
earnings
Anteris Announces Results for the First Quarter of 2026
Anteris Announces Results for the First Quarter of 2026
May 11, 2026
earnings_calendar
AVR Q1 2026 Earnings Scheduled — 2026-05-11
May 5, 2026
other
Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial
Anteris Technologies Announces the First U.S. Patients Treated in the Global Pivotal PARADIGM Trial
Apr 28, 2026
other
Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial
Anteris Technologies secures CMS reimbursement supporting U.S. site activation for the global pivotal PARADIGM Trial evaluating the DurAVR THV
Mar 23, 2026
short_interest
FTD: AVR — 180,523 shares ($1.0M) failed to deliver
Settlement: 20260323, Price: $5.60, FTD Value: $1,010,928.8, ANTERIS TECHNOLOGIES GLOBAL CO